Clinical ArticlePharmacology Spina Bifida and Urinary Tract Infection ManagementBhandal, Amrinder PharmD Candidate; Muhar, Harleen K. PharmD Candidate Author Information Amrinder Bhandal and Harleen Muhar are 2023 PharmD candidates at Touro University California, Vallejo College of Pharmacy. Both of the authors declare no conflicts of interest nor any affiliation with the drug manufacturers or societies that are mentioned in this article. Correspondence: Amrinder Bhandal, PharmD Candidate, Touro University California, 1310 Club Dr, Vallejo, CA 94592. E-mail: [email protected] Journal of Pediatric Surgical Nursing ():10.1097/JPS.0000000000000368, January 16, 2023. | DOI: 10.1097/JPS.0000000000000368 Buy PAP Metrics Abstract Spina bifida is one of the congenital neural tube defects that can lead to loss of bladder control, also known as neurogenic bladder. This can lead to recurrent urinary tract infections and subsequent renal function decline if not properly managed. Proper management may include pharmacological care that aims to prevent improper drainage of the bladder directly by utilizing agents such as anticholinergics, urinary antispasmodics, and botulism toxins. In addition to direct care, patients with neurogenic bladder also may require bowel regimens because of concurrent instances of neurogenic bowels. Copyright © 2023 American Pediatric Surgical Nursing Association, Inc.